AAAAAA

   
Results: 1-20 |

Table of contents of journal:

Results: 20

Authors: Sabri, MI Spencer, PS Baggia, S Ludolph, AC
Citation: Mi. Sabri et al., Clinical manifestations and mechanisms of action of environmental mitochondrial toxins, CONT NEUROS, 2000, pp. 3-19

Authors: Hamilton, BF Gould, DH Gustine, DL
Citation: Bf. Hamilton et al., History of 3-nitropropionic acid - Occurrence and role in human and animaldisease, CONT NEUROS, 2000, pp. 21-33

Authors: Reynolds, NC Lin, W
Citation: Nc. Reynolds et W. Lin, The neurochemistry of 3-nitropropionic acid, CONT NEUROS, 2000, pp. 35-49

Authors: Zeevalk, GD
Citation: Gd. Zeevalk, In vitro studies of 3-nitropropionic acid, CONT NEUROS, 2000, pp. 53-72

Authors: Dunbar, GL Shear, DA Dong, J Haik-Creguer, KL
Citation: Gl. Dunbar et al., Cognitive and motor deficits produced by acute and chronic administration of 3-nitropropionic acid in rats, CONT NEUROS, 2000, pp. 73-92

Authors: Borlongan, CV Shimizu, T Sanberg, PR
Citation: Cv. Borlongan et al., Comparative study on 3-nitropropionic acid neurotoxicity, CONT NEUROS, 2000, pp. 93-106

Authors: Geddes, JW Bondada, V Pang, Z
Citation: Jw. Geddes et al., Mechanisms of 3-nitropropionic acid neurotoxicity, CONT NEUROS, 2000, pp. 107-120

Authors: Nakajima, K Shimano, Y Torii, K Nishino, H
Citation: K. Nakajima et al., Gender-related difference of the effect of 3-nitropropionic acid on striatal artery, CONT NEUROS, 2000, pp. 121-127

Authors: Alexi, T Faull, RLM Hughes, PE
Citation: T. Alexi et al., Variable susceptibility to neurotoxicity of systemic 5-nitropropionic acid, CONT NEUROS, 2000, pp. 129-140

Authors: Page, KJ Meldrum, A Dunnett, SB
Citation: Kj. Page et al., The 3-nitropropionic acid model of Huntington's disease - Do alterations in the expression of metabolic mRNAs predict the development of striatal pathology?, CONT NEUROS, 2000, pp. 141-156

Authors: Kumazaki, M Ungsuparkorn, C Deshpande, SB Fukuda, A Nishino, H
Citation: M. Kumazaki et al., Mechanisms of action of 3-nitropropionic acid - Dopamine overflow and vulnerability of the lateral striatal artery, CONT NEUROS, 2000, pp. 157-165

Authors: Behrens, MI
Citation: Mi. Behrens, Mitochondrial inhibition and neuronal death in Huntington's disease, CONT NEUROS, 2000, pp. 167-176

Authors: Gabbita, SP Carney, JM Butterfield, A
Citation: Sp. Gabbita et al., Effects of brain mitochondrial metabolism, aging, and caloric restriction on membrane lipids and proteins - An electron paramagnetic resonance investigation, CONT NEUROS, 2000, pp. 177-200

Authors: Meldrum, A Page, KJ Everitt, BJ Dunnett, SB
Citation: A. Meldrum et al., Malonate - Profile and mechanisms of striatal toxicity, CONT NEUROS, 2000, pp. 201-217

Authors: Bazzett, TJ Albin, RL Becker, JB
Citation: Tj. Bazzett et al., Malonic acid and the chronic administration model of excitotoxicity, CONT NEUROS, 2000, pp. 219-231

Authors: Yang, Y Borlongan, CV
Citation: Y. Yang et Cv. Borlongan, Sodium azide-induced neurotoxicity, CONT NEUROS, 2000, pp. 233-242

Authors: Riepe, MW
Citation: Mw. Riepe, Neuroprotective strategies against cellular hypoxia, CONT NEUROS, 2000, pp. 245-263

Authors: Binienda, ZK Scallet, AC
Citation: Zk. Binienda et Ac. Scallet, Neuroprotective effect of perinatal hypoxia against 3-nitropropionic acid neurotoxicity, CONT NEUROS, 2000, pp. 265-274

Authors: Borlongan, CV Stahl, CE Freeman, TB Hauser, RA Sanberg, PR
Citation: Cv. Borlongan et al., Neural transplantation and Huntington's disease - What can we learn from the 3-nitropropionic acid model?, CONT NEUROS, 2000, pp. 275-291

Authors: Youdim, MBH Krishna, G Chiueh, CC
Citation: Mbh. Youdim et al., Neuroprotective strategies in Parkinson's disease and Huntington's chorea - MPTP- and 3-NPA-induced neurodegeneration as models, CONT NEUROS, 2000, pp. 293-309
Risultati: 1-20 |